CYCURIA
LIVE

Serial Number

79413314

Owner

Cycuria GmbH

Attorney

Alisa C. Simmons

Filing Date

Nov 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CYCURIA Trademark

Serial Number: 79413314 • Registration: 8163961

CYCURIA is a trademark filed by Cycuria GmbH on November 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Cycuria GmbH

Stiftingtalstraße 14

Entity Type: 27

Cycuria Therapeutics GmbH

Stiftingtalstraße 14

Entity Type: 98

Trademark Details

Filing Date

November 12, 2024

Registration Date

March 10, 2026

Published for Opposition

January 20, 2026

Goods & Services

Pharmaceutical preparations and formulations, and medicated health preparations, for use in the treatment or prevention of human and animal diseases, disorders and conditions, especially circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic and gastrointestinal diseases, disorders and conditions, and the treatment or prevention of complications associated with such diseases, disorders and conditions; pharmaceutical preparations and formulations, and medicated health preparations, for use in the treatment or prevention of human and animal diseases, disorders and conditions, especially bone sensory, viral, urinary, renal, metabolic and central nervous system diseases, disorders and conditions, and the treatment or prevention of complications associated with such diseases, disorders and conditions; pharmaceutical preparations and formulations, and medicated health preparations, for use in the treatment or prevention of human and animal diseases, disorders and conditions, especially infectious, auto-immune and immune-related, cell-proliferative and oncologic diseases, disorders and conditions, cancers, tumours and metastases, and the treatment or prevention of complications associated with such diseases, disorders and conditions; diagnostic preparations and biomarker reagents for medical or veterinary purposes; diagnostic preparations and biomarker reagents for the diagnosis and prognosis of human and animal diseases, disorders and conditions, especially circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic and gastrointestinal diseases, disorders and conditions, and the diagnosis and prognosis of complications associated with such diseases, disorders and conditions; diagnostic preparations and biomarker reagents for the diagnosis and prognosis of human and animal diseases, disorders and conditions, especially bone sensory, viral, urinary, renal, metabolic and central nervous system diseases, disorders and conditions, and the diagnosis and prognosis of complications associated with such diseases, disorders and conditions; diagnostic preparations and biomarker reagents for the diagnosis and prognosis of human and animal diseases, disorders and conditions, especially infectious, auto-immune and immune-related, cell-proliferative and oncologic diseases, disorders and conditions, cancers, tumours and metastases, and the diagnosis and prognosis of complications associated with such diseases, disorders and conditions.

Scientific services and research relating thereto, namely, scientific research; Scientific services and research relating thereto, namely, scientific research and development; Scientific services and research relating thereto, namely, scientific research for medical purposes in the field of cancerous diseases; Scientific services and research relating thereto, namely, scientific research, analysis, and testing in the fields of genomics, genetics, genetic engineering, biotechnology, and medicine; Scientific services and research relating thereto, namely, providing scientific research information in the field of genetics; Scientific services and research relating thereto, namely, providing scientific research information in the field of pharmaceuticals; Scientific services and research relating thereto, namely, scientific laboratory services; Scientific services and research relating thereto, namely, scientific research and scientific research information in the field of pharmaceuticals and clinical trials and conducting clinical trials for others; scientific services and research relating thereto, namely, scientific research, scientific research and development, analysis, and testing, and providing of scientific research information in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents and diagnostic apparatus; scientific services and research thereto, namely, scientific research, scientific research and development, analysis, and testing, and providing of scientific research information in the field of discovery of drug targets and drug candidates for the treatment or diagnostics of diseases, disorders and conditions in humans and animals, in particular in the fields of oncology, inflammatory-, autoimmune- and metabolic diseases; providing technical and scientific information about a biotechnology company, its technologies, projects, product-candidates, products and services via a web site on a global computer network; design and development of computer software; design and development of computer software for use in the fields of biology, chemistry or medicine, especially immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry, as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents and diagnostic apparatus.

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 10, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 20, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 20, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 14, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2025 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 28, 2025 ADCH
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Aug 12, 2025 CORR
REFUSAL PROCESSED BY IB
Jul 12, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 22, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 22, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 24, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 23, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 15, 2025 DOCK
CORRECTION TRANSACTION RECEIVED FROM IB
Feb 14, 2025 CRCV
APPLICATION FILING RECEIPT MAILED
Dec 27, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 26, 2024 REPR